AKAM
Akamai Technologies, Inc.
AKAM trails on the overall score without a compensating advantage in the available component scores.
MU
Micron Technology, Inc.
MU has the edge over AKAM overall, supported by stronger valuation and stronger fundamentals.
AKAM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Weak |
AKAM's revenue, profitability and cash flow are currently stable, but its balance sheet is weak.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
AKAM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $86.56 | — |
| Cheap | 25x | $65.50 | -24% |
| Fair | 30x | $77.92 | -10% |
| Expensive | 34x | $88.53 | +2.3% |
| Current | 34x | $86.56 | — |
Historical ranges are pointers, not guarantees.
AKAM has the edge over MU in the historical PE scenario, which offers more potential upside but is not a forecast.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 4.6x next year's earnings.
AKAM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Growth | |
| Strongly weakening | |
| Moderate | |
| Moderate |
Analysts expect AKAM's revenue to grow, but its profitability to weaken.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
MU has the edge over AKAM on the outlook, with more favorable earnings and profitability expectations.
AKAM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.44 | +150% |
| Q3 2026 | $2.57 | -25% |
| Q2 2026 | $2.77 | -2.1% |
| Q1 2026 | $2.96 | -0.7% |
| Q4 2025 | $3.07 | -6.1% |
| Q3 2025 | $3.42 | +1.5% |
| Q2 2025 | $2.83 | -30% |
| Q1 2025 | $2.98 | -26% |
| Q4 2024 | $3.27 | -7.1% |
AKAM's earnings per share have fallen from their peak: $2.57 over the past year, against $4.03 in mid-2024.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over AKAM on earnings, with more consistent year-over-year improvement.
AKAM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +6.4% |
| Q2 2026 | $1.1B | +5.4% |
| Q1 2026 | $1.1B | +5.8% |
| Q4 2025 | $1.1B | +7.4% |
| Q3 2025 | $1.1B | +5% |
| Q2 2025 | $1B | +6.5% |
| Q1 2025 | $1B | +2.9% |
| Q4 2024 | $1B | +2.5% |
AKAM's revenue has grown year over year every quarter since late 2020: $1.1B last quarter, up 6.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.7% | -6.1 points |
| Q2 2026 | 7.3% | -7.2 points |
| Q1 2026 | 11% | -4.6 points |
| Q4 2025 | 8.7% | -5.8 points |
| Q3 2025 | 16% | +8.7 points |
| Q2 2025 | 15% | -0.6 points |
| Q1 2025 | 15% | -1.7 points |
| Q4 2024 | 15% | -4.1 points |
AKAM's operating margin was 9.7% last quarter, down 6.1 points from the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over AKAM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over AKAM on profitability, with a higher operating margin.
AKAM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$81.9M | -125% |
| Q2 2026 | $181.3M | -42% |
| Q1 2026 | $210.8M | +58% |
| Q4 2025 | $234.9M | -6.4% |
| Q3 2025 | $329.1M | +18% |
| Q2 2025 | $313.6M | -7.8% |
| Q1 2025 | $133.4M | -48% |
| Q4 2024 | $250.9M | -21% |
AKAM usually generates cash, though not every quarter: the latest was −$82M, but it generated $545M over the past year.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over AKAM on cash flow, with more consistent year-over-year improvement.
AKAM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.6x | High |
| Q2 2026 | 5.1x | High |
| Q1 2026 | 2.8x | Moderate |
| Q4 2025 | 2.5x | Moderate |
| Q3 2025 | 2.4x | Moderate |
| Q2 2025 | 2.7x | Moderate |
| Q1 2025 | 2.1x | Moderate |
| Q4 2024 | 2.6x | Moderate |
AKAM's net debt is about 5.6 years of its operating earnings (EBITDA), up from 2.4 years a year ago.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has the edge over AKAM on leverage, with a lower net debt burden relative to earnings.
AKAM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.1 | Neutral |
| Stochastic | 15.0 | Oversold |
AKAM's weekly RSI is 39 (neutral) and its Stochastic is 15 (oversold).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
AKAM PE vs Technology Sector
| Metric | AKAM | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 28x | 21% above |
| PE % | 79 | 35 | 44 pts above |
AKAM is trading at 34x earnings, a 21% premium to the Technology sector's median of 28x.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over AKAM on valuation relative to its sector.
AKAM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $96.7 | 10% below |
| 20 week MA | $106.7 | 19% below |
| 50 week MA | $107.8 | 20% below |
| 100 week MA | $94.7 | 8.6% below |
| 200 week MA | $96.5 | 10% below |
AKAM is in a downtrend: it's below all five of its weekly moving averages, and 10% below its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has the edge over AKAM on trend strength, trading above more of its moving averages.
AKAM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $86.5 | $107.5 | +24% |
| 2021 | $107.5 | $116.2 | +8.1% |
| 2022 | $116.2 | $83.2 | -28% |
| 2023 | $83.2 | $118.4 | +42% |
| 2024 | $118.4 | $97.0 | -18% |
| 2025 | $97.0 | $88.4 | -8.8% |
| 2026 YTD | $88.4 | $86.6 | -2.1% |
AKAM has finished lower in three of the last six years. It's down 2.1% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over AKAM on returns for 2026, with the stronger performance.